Nikko Asset Management Americas, Inc. Surface Oncology, Inc. Transaction History

Nikko Asset Management Americas, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$0.61 - $1.03 $44,522 - $75,176	-72,987 Reduced 6.81%	999,026 $699,000
Q4 2022 Feb 13, 2023	SELL	$0.62 - $1.21 $19,974 - $38,982	-32,217 Reduced 2.92%	1,072,013 $879,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.1 $1.16 Million - $2.32 Million	1,104,230 New	1,104,230 $1.1 Million

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.